<code id='6D083AE9DA'></code><style id='6D083AE9DA'></style>
    • <acronym id='6D083AE9DA'></acronym>
      <center id='6D083AE9DA'><center id='6D083AE9DA'><tfoot id='6D083AE9DA'></tfoot></center><abbr id='6D083AE9DA'><dir id='6D083AE9DA'><tfoot id='6D083AE9DA'></tfoot><noframes id='6D083AE9DA'>

    • <optgroup id='6D083AE9DA'><strike id='6D083AE9DA'><sup id='6D083AE9DA'></sup></strike><code id='6D083AE9DA'></code></optgroup>
        1. <b id='6D083AE9DA'><label id='6D083AE9DA'><select id='6D083AE9DA'><dt id='6D083AE9DA'><span id='6D083AE9DA'></span></dt></select></label></b><u id='6D083AE9DA'></u>
          <i id='6D083AE9DA'><strike id='6D083AE9DA'><tt id='6D083AE9DA'><pre id='6D083AE9DA'></pre></tt></strike></i>

          entertainment

          entertainment

          author:explore    Page View:68931
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Public health communication lessons from Covid
          Public health communication lessons from Covid

          KENABETANCUR/AFPviaGettyImagesNowthattheCovid-19publichealthemergencyhasended,it’sawfullytemptingtop

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Even great ERs can’t make up for American health disparities

          PhotobyScottOlson/GettyImagesFrom“Legacy”byUchéBlackstock,M.D.,publishedbyViking,animprintofPenguinP